83 results
DEFA14A
EX-99.1
IMGN
Immunogen, Inc.
30 Nov 23
Additional proxy soliciting materials
4:07pm
forces with innovative partners to accelerate the delivery of potentially breakthrough medicines. We are evaluating more than 20 investigational … www.abbvie.com/oncology.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today
8-K
EX-99.1
IMGN
Immunogen, Inc.
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm
forces with innovative partners to accelerate the delivery of potentially breakthrough medicines. We are evaluating more than 20 investigational … www.abbvie.com/oncology.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today
8-K
EX-99.1
IMGN
Immunogen, Inc.
6 Apr 23
ImmunoGen Announces Non-Dilutive Term Loan Financing for Up to $175 Million with Pharmakon Advisors
6:35am
Enyedy, ImmunoGen's President and Chief Executive Officer. "Pharmakon is a well-respected partner to innovative biotechnology companies, and we look
8-K
EX-99.1
IMGN
Immunogen, Inc.
14 Nov 22
ImmunoGen Announces FDA Accelerated Approval of ELAHERE™ (mirvetuximab soravtansine-gynx) for the Treatment of Platinum-Resistant Ovarian Cancer
5:23pm
company and the start of an exciting new chapter for us as a leader in the development and commercialization of innovative oncology products. With a highly
8-K
EX-99.1
a60 x7o9tz
10 Jan 22
Results of Operations and Financial Condition
7:30am
8-K
EX-99.1
c55cyk07
30 Jul 21
ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results
6:36am
8-K
EX-99.1
czikxo
10 May 21
ImmunoGen Reports Recent Progress and First Quarter 2021 Financial Results
6:36am
8-K
EX-99.1
gnts6 coa
11 Jan 21
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
gepfze yswo
19 Oct 20
ImmunoGen and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize Mirvetuximab Soravtansine in Greater China
8:57am
424B5
pfwmdccp ewtt
25 Sep 20
Prospectus supplement for primary offering
4:23pm
424B5
geksnamzj81rr
23 Jan 20
Prospectus supplement for primary offering
4:05pm